FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity.

Sahoo, Subhransu S; Ramanand, Susmita G; Gao, Yunpeng; Abbas, Ahmed; Kumar, Ashwani; Cuevas, Ileana C; Li, Hao-Dong; Aguilar, Mitzi; Xing, Chao; Mani, Ram S; Castrillon, Diego H

Sahoo, Subhransu S; Ramanand, Susmita G; Gao, Yunpeng; Abbas, Ahmed; Kumar, Ashwani; Cuevas, Ileana C; Li, Hao-Dong; Aguilar, Mitzi; Xing, Chao; Mani, Ram S; Castrillon, Diego H.

Afiliação

Sahoo SS; Department of Pathology.
Ramanand SG; Department of Pathology.
Gao Y; Department of Pathology.
Abbas A; Department of Pathology.
Kumar A; Eugene McDermott Center for Human Growth and Development.
Cuevas IC; Department of Pathology.
Li HD; Department of Pathology.
Aguilar M; Department of Pathology.
Xing C; Eugene McDermott Center for Human Growth and Development.
Mani RS; Department of Bioinformatics.
Castrillon DH; Department of Population and Data Sciences.

J Clin Invest ; 132(12)2022 06 15.

Article em En | MEDLINE | ID: mdl-35703180

Assuntos

Neoplasias do Endométrio; Transição Epitelial-Mesenquimal; Animais; Carcinogênese/genética; Linhagem Celular Tumoral; Neoplasias do Endométrio/genética; Transição Epitelial-Mesenquimal/genética; Feminino; Fator 3-beta Nuclear de Hepatócito/genética; Fator 3-beta Nuclear de Hepatócito/metabolismo; Humanos; Camundongos; Fosfatidilinositol 3-Quinases

Palavras-chave

Cancer; Molecular pathology; Oncology; Tumor suppressors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Transição Epitelial-Mesenquimal Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google